Biofrontera (BFRI) Free Cash Flow (2020 - 2025)

Biofrontera's Free Cash Flow history runs 6 years deep, the most recent figure standing at -$2.4 million for Q4 2025.

• On a quarterly basis, Free Cash Flow fell 141.16% year-over-year to -$2.4 million in Q4 2025; TTM through Dec 2025 was -$13.4 million, a 29.99% decrease from a year earlier, with the FY2025 full-year figure at -$13.4 million, down 29.99% from the prior year.
• Free Cash Flow grew to -$2.4 million in Q4 2025 per BFRI's latest filing, from -$3.8 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $82000.0 in Q2 2022 and bottomed at -$21.0 million in Q4 2021.
• The 5-year median for Free Cash Flow is -$3.4 million (2021), against an average of -$4.6 million.
• Across the five-year window, Free Cash Flow soared 107.4% in 2022 and tumbled 14079.27% in 2023, its largest moves.
• Year by year, Free Cash Flow stood at -$21.0 million in 2021, then jumped by 60.49% to -$8.3 million in 2022, then dropped by 6.7% to -$8.9 million in 2023, then soared by 88.7% to -$1.0 million in 2024, then slumped by 141.16% to -$2.4 million in 2025.
• Per Business Quant, the three latest BFRI Free Cash Flow figures stand at -$2.4 million (Q4 2025), -$3.8 million (Q3 2025), and -$3.1 million (Q2 2025).